Published in J Artif Organs on January 01, 2005
Clinical application of computer-aided diagnostic system for harmonious introduction of complementary dialysis therapy. Open Biomed Eng J (2008) 0.75
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res (1987) 10.80
Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int (1990) 1.71
Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl (2002) 1.16
AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int (2002) 1.05
Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int (1999) 0.93
Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int (1993) 0.93
Effects of peritoneal rest on peritoneal transport and peritoneal membrane thickening in continuous ambulatory peritoneal dialysis rats. Perit Dial Int (1999) 0.91
3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int (2002) 0.91
Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int (1996) 0.88
Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron (1993) 0.87
Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int (2000) 0.87
In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol (1996) 0.83
Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products. Clin Exp Immunol (2004) 0.83
Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure. Adv Perit Dial (1993) 0.82
Two-stage isolation procedure for obtaining homogenous populations of microvascular endothelial and mesothelial cells from human omentum. Microvasc Res (1997) 0.80
Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease. Ther Apher Dial (2004) 0.80
Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations. Perit Dial Int (1995) 0.79
Five years' experience of combination therapy: peritoneal dialysis with hemodialysis. Adv Perit Dial (2002) 0.75
Hemodialysis together with peritoneal dialysis is one of the simplest ways to maintain adequacy in continuous ambulatory peritoneal dialysis. Adv Perit Dial (1999) 0.75
Combined peritoneal dialysis and hemodialysis: our experience compared to others. Perit Dial Int (2003) 0.75
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. J Gastroenterol (2013) 2.22
Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol (2007) 1.45
Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis. Intern Med (2004) 1.44
Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis. Intern Med (2005) 1.41
Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography. Am J Gastroenterol (2002) 1.11
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med (2004) 1.01
Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol (2004) 0.91
Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol (2005) 0.90
Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction. Circ J (2003) 0.88
Computed tomography findings of aspiration pneumonia in 53 patients. Geriatr Gerontol Int (2012) 0.87
Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients. Circ J (2003) 0.87
Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients. J Clin Microbiol (2003) 0.85
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)]. Jpn J Antibiot (2003) 0.85
[Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis]. Nihon Ishinkin Gakkai Zasshi (2003) 0.85
Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice. FEMS Immunol Med Microbiol (2006) 0.85
Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection. Microbiol Immunol (2002) 0.84
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)]. Jpn J Antibiot (2002) 0.84
Increased release of glucuronoxylomannan antigen and induced phenotypic changes in Trichosporon asahii by repeated passage in mice. J Med Microbiol (2002) 0.83
Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter (2003) 0.83
Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene. Helicobacter (2002) 0.82
Bird fancier's lung complicated by pulmonary nocardiosis. J Bras Pneumol (2013) 0.82
Circulating tenascin-C levels in patients with idiopathic dilated cardiomyopathy. Am J Cardiol (2004) 0.81
Identification and characterization of a soluble cadherin-7 isoform produced by alternative splicing. J Biol Chem (2002) 0.81
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin. BMC Infect Dis (2012) 0.81
Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae. Int J Antimicrob Agents (2004) 0.80
Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol (2003) 0.80
Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid. J Artif Organs (2007) 0.80
Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. J Gastroenterol (2002) 0.79
Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia. Int J Hematol (2004) 0.79
Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates. J Med Microbiol (2004) 0.79
Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study. J Gastroenterol (2013) 0.79
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. J Gastroenterol Hepatol (2006) 0.78
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)]. Jpn J Antibiot (2004) 0.78
Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages. Antimicrob Agents Chemother (2003) 0.78
Antibiotic-induced apoptosis in human activated peripheral lymphocytes. Int J Antimicrob Agents (2005) 0.78
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. Antimicrob Agents Chemother (2004) 0.78
Intraperitoneal immunization led to T cell hyporesponsiveness to Helicobacter pylori infection in mice. Microbiol Immunol (2002) 0.78
Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant. Int J Hematol (2004) 0.78
The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis. Respir Med (2006) 0.78
Sex differences in the prevalence, progression, and improvement of chronic kidney disease. Kidney Blood Press Res (2014) 0.78
Synergistic cytotoxicity of acidity and 3,4-Dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid. Ther Apher Dial (2005) 0.77
Risk factors for unexpected death from suffocation in elderly patients hospitalized for pneumonia. Geriatr Gerontol Int (2012) 0.76
Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection. Int J Antimicrob Agents (2003) 0.76
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)]. Jpn J Antibiot (2006) 0.76
Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids. Nephrol Dial Transplant (2008) 0.76
Synergistic cytotoxicity of acidity and glucose degradation products in peritoneal dialysis fluid. J Artif Organs (2004) 0.76
Physicians' attitudes toward the definition of "death from age-related physical debility" in deceased elderly with aspiration pneumonia. Geriatr Gerontol Int (2012) 0.76
Effect of hemodiafiltration against radical stress in the course of blood purification. Blood Purif (2004) 0.76
Prolonged remission of adult T-cell leukemia/lymphoma treated with interferon-gamma following autologous peripheral blood stem cell transplantation. Leuk Lymphoma (2005) 0.76
Significance of neutrophil counts after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Circ J (2005) 0.75
The transcription factor CCAAT-binding factor CBF/NF-Y and two repressors regulate the core promoter of the human pro-alpha3(V) collagen gene (COL5A3). J Biol Chem (2004) 0.75
Evaluation of the Helicobacter pylori stool antigen (HpSA) assay for diagnosing infection and confirming eradication after treatment. J Gastroenterol (2004) 0.75
[Intravascular device-related infection]. Nihon Rinsho (2002) 0.75
[A case of adult-onset Still's disease complicated with acute respiratory distress syndrome]. Nihon Kokyuki Gakkai Zasshi (2002) 0.75
[Toward eradication of refractory respiratory infections--Pseudomonas infection of the respiratory system]. Nihon Naika Gakkai Zasshi (2005) 0.75
Association of peripheral mononuclear cells containing Chlamydia pneumoniae DNA with acute coronary syndrome and stable coronary artery disease in Japanese subjects. Clin Infect Dis (2004) 0.75
Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases. Int J Antimicrob Agents (2004) 0.75
Clinical usefulness of a new hepatitis C virus RNA extraction method using specific capture probe and magnetic particle in hemodialysis patients. Ther Apher Dial (2004) 0.75
[Drug sensitivity test for Helicobacter pylori]. Nihon Rinsho (2002) 0.75
[Management of respiratory infections in lung cancer]. Nihon Rinsho (2002) 0.75
Myeloid/natural killer cell precursor acute leukaemia with minor bcr/abl mRNA transcript. Br J Haematol (2002) 0.75
[A case of Pseudomans aeruginosa pneumonia complicated with multiple pustular skin lesions]. Kansenshogaku Zasshi (2002) 0.75
Effect of preinfarction angina on heart rate variability in the early phase of the first anterior wall acute myocardial infarction. Circ J (2002) 0.75
[A multicenter study of a new Helicobacter pylori selective medium. Columbia horse blood agar HP]. Kansenshogaku Zasshi (2002) 0.75
Sai-rei-to-induced lung injury: a case report and brief review of the literature. Intern Med (2012) 0.75
[Positioning of various anti-bacterial agents and their appropriate application in the era of multiple bacterial drug resistance. 1. Penicillins]. Nihon Naika Gakkai Zasshi (2003) 0.75
[Therapies for intractable respiratory infection due to Pseudomonas aeruginosa]. Nihon Naika Gakkai Zasshi (2005) 0.75
[Results of survey of adult community-acquired pneumonia utilizing flow chart of diagnostic guideline for management of respiratory infections]. Nihon Kokyuki Gakkai Zasshi (2003) 0.75
[Recent topics on important drugs for H. pylori eradication: Amoxicillin (AMPC)]. Nihon Rinsho (2005) 0.75
[Effect of macrolide antibiotics on induction of apoptosis in activated lymphocytes]. Jpn J Antibiot (2003) 0.75
[Proper use of carbapenem antibiotics based on the feature in the treatment of infectious diseases (discussion)]]. Jpn J Antibiot (2004) 0.75
[Clarithromycin (CAM)]. Nihon Rinsho (2002) 0.75
Relationship between heart rate variability and left ventricular remodeling after reperfused first anterior wall acute myocardial infarction. Circ J (2003) 0.75
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2003)]. Jpn J Antibiot (2005) 0.75
[New effects of antimicrobial agents other than antimicrobial activity]. Nihon Rinsho (2003) 0.75
Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. J Gastroenterol Hepatol (2006) 0.75
[A case of simple ulcer with ulcerative colitis]. Nihon Shokakibyo Gakkai Zasshi (2005) 0.75
Interferon therapy for hepatitis C virus (HCV)-related advanced chronic hepatitis after treatment of recurrent hepatocellular carcinoma: a successful case. Intern Med (2002) 0.75
Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapy. Intervirology (2014) 0.75
Natural killer cell-type body cavity lymphoma following chronic active Epstein-Barr virus infection. Am J Hematol (2003) 0.75
[Culture method for H. pylori]. Nihon Rinsho (2003) 0.75
[Infectious endocarditis revealed by the rupture of bacterial cerebral aneurysm under the treatment of spondylodicitis]. Nihon Naika Gakkai Zasshi (2005) 0.75
Response to cyclosporine therapy in patients with myelodysplastic syndrome: a clinical study of 12 cases and literature review. Int J Hematol (2004) 0.75
[Quality control for antimicrobial susceptibility test using correlation between MIC results]. Rinsho Byori (2002) 0.75
[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection]. Nihon Rinsho (2002) 0.75
[The mechanism of apoptosis induction in lymphocytes by macrolide antibiotics and the related intra-cellular molecular structure]. Jpn J Antibiot (2004) 0.75
[A case of suspected lung metastasis of pancreatic carcinoma with bronchorrhea similar to bronchioloalveolar carcinoma]. Nihon Kokyuki Gakkai Zasshi (2002) 0.75
Effect of high fiber density ratio polysulfone dialyzer on protein removal. Blood Purif (2008) 0.75